Showing 1051-1060 of 5603 results for "".
Advancing gMG Clinical Decisions: Diagnosing Early, Treating Smarter, and Caring Holistically – A Case-Based Treatment Approach
https://reachmd.com/programs/cme/advancing-gmg-clinical-decisions-diagnosing-early-treating-smarter-and-caring-holistically-a-case-based-treatment-approach/36276/Advancing gMG Clinical Decisions: Diagnosing Early, Treating Smarter, and Caring Holistically – A Case-Based Treatment ApproachFetal and Neonatal Alloimmune Thrombocytopenia (FNAIT): Overcoming Diagnostic and Therapeutic Challenges
https://reachmd.com/programs/cme/fetal-and-neonatal-alloimmune-thrombocytopenia-fnait-overcoming-diagnostic-and-therapeutic-challenges/29105/FNAIT is the platelet equivalent of Rh disease. Managing this alloimmune disorder of pregnancy poses many challenges for clinicians. Learn more here!Progress in Breast Cancer Care: Translating SABCS Data Into Practice
https://reachmd.com/programs/cme/progress-in-breast-cancer-care-translating-sabcs-data-into-practice/48989/Learn to integrate the latest data on ADCs in breast cancer into clinical practice, expand treatment options, and apply emerging evidence in real-world care.Decision in Context: A Practical Framework for Sequencing Systemic and CNS Therapies in Brain Metastases
https://reachmd.com/programs/cme/decision-in-context-a-practical-framework-for-sequencing-systemic-and-cns-therapies-in-brain-metastases/54765/Apply clinical evidence on intracranial activity of systemic therapies to guide treatment sequencing and multidisciplinary care in brain metastases.BRCA and HRD Biomarker Testing in Advanced Ovarian Cancer: A KOL Panel Discussion
https://reachmd.com/programs/medical-industry-feature/brca-and-hrd-biomarker-testing-in-advanced-ovarian-cancer-a-kol-panel-discussion/37649/Certain advanced ovarian cancer patients—including those with BRCA mutations and/or homologous recombination deficiency (HRD) who are in response to first-line platinum-based chemotherapy—may show improved outcomes when treated with poly (ADP-ribose) polymerase (PARP) inhibitor maintenance therapy.1Recognizing Multiple Sclerosis Awareness Month: Ways to Make an Impact
https://reachmd.com/programs/neurofrontiers/recognizing-multiple-sclerosis-awareness-month-ways-to-make-an-impact/32369/March is Multiple Sclerosis Awareness Month. Learn about how you can support patients and raise awareness through education, advocacy, and community engagement.Beauty Counter MD/New Products
https://reachmd.com/topics/skincare/beauty-counter-mdnew-products/35164/Expert insight on the hottest products, ingredients, and trends your patients are talking aboutNicotinamide for COVID-19 Recovery: Restoring Metabolic Balance
https://reachmd.com/programs/clinicians-roundtable/nicotinamide-for-covid-19-recovery-restoring-metabolic-balance/36410/Make Filler Great Again
https://reachmd.com/ma-issues-index/2025-mar-apr/make-filler-great-again-restoring-balance-function-and-trust/36063/Restoring balance, function, and trustBeauty Counter MD
https://reachmd.com/topics/skincare/beauty-counter-md-17/35182/Expert insight on the hottest products, ingredients, and trends your patients are talking about.